(Q37874043)

24 August 2017

0 references

1 reference

title

Effect of interferon-alpha-based antiviral therapy on hepatitis C virus-associated glomerulonephritis: a meta-analysis (English)

1 reference

24 August 2017

0 references

1 reference

1 reference

1 reference

2

Garabed Eknoyan

1 reference

24 August 2017

Bo Feng

1

1 reference

24 August 2017

Zhong-Sheng Guo

3

1 reference

24 August 2017

Michel Jadoul

4

1 reference

24 August 2017

Hui-Ying Rao

5

1 reference

24 August 2017

Wei Zhang

6

1 reference

24 August 2017

Lai Wei

7

1 reference

24 August 2017

language of work or name

English

0 references

publication date

10 May 2011

1 reference

Nephrology Dialysis Transplantation

24 August 2017

1 reference

24 August 2017

27

1 reference

24 August 2017

2

1 reference

24 August 2017

640-646

1 reference

Association of hepatitis C seropositivity with increased risk for developing end-stage renal disease

24 August 2017

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR236

Hepatitis C is a predictor of poorer renal survival in diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR236

Hepatitis C virus RNA and core protein in kidney glomerular and tubular structures isolated with laser capture microdissection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR236

Hepatitis C infection and chronic renal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR236

Influence of antiviral therapy in hepatitis C virus-associated cryoglobulinemic MPGN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR236

Hepatitis C virus: from entry to renal injury--facts and potentials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR236

Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR236

Membranoproliferative glomerulonephritis associated with hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR236

A comprehensive study of the association between hepatitis C virus and glomerulopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR236

Diagnosis, management, and treatment of hepatitis C: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR236

Interferon-alpha in combination with ribavirin as initial treatment for hepatitis C virus-associated cryoglobulinemic membranoproliferative glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR236

Interferon alpha and ribavirin for membranoproliferative glomerulonephritis and hepatitis C infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR236

Hepatitis C virus-related cryoglobulinemic glomerulonephritis: long-term remission after antiviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR236

Severe exacerbation of hepatitis C-associated vasculitic neuropathy following treatment with interferon alpha: a case report and literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR236

Exacerbation of glomerulonephritis in subjects with chronic hepatitis C virus infection after interferon therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR236

Membranoproliferative glomerulonephritis associated with hepatitis C virus infection responsive to interferon-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR236

Interferon versus steroids in patients with hepatitis C virus-associated cryoglobulinaemic glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR236

Quantifying heterogeneity in a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR236

The clinical and morphologic spectrum of renal cryoglobulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR236

Interferon and ribavirin treatment in patients with hepatitis C-associated renal disease and renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR236

Hepatitis C virus-associated glomerulonephritis. Effect of alpha-interferon therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR236

Interferon/pegylated interferon and ribavirin in HCV-associated kidney disease with or without cryoglobulinemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR236

Detection of hepatitis C viral sequences in formalin-fixed, paraffin-embedded liver tissue: effect of interferon alpha therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR236

Successful cyclophosphamide treatment of cryoglobulinemic membranoproliferative glomerulonephritis associated with hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR236

21 January 2018

Identifiers

DOI

10.1093/NDT/GFR236

1 reference

24 August 2017

1 reference